Evidence map›Paper›PMID 42082669›Full record

ArticleAnalytical and bioanalytical chemistry2026

DDA/DIA mass spectrometry coupled with molecular networking and machine learning: high-coverage profiling of pyrrolizidine alkaloids.

Qiaoli Lu, Huitai Luo, Jiaqi Lu, Chang Liu, Xi Zhou, Huihui Ti

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiaoli LuCenter for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Huitai LuoGuangdong Provincial Engineering Research Center for Quality and Safety of Traditional Chinese Medicine, Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, China.
Jiaqi LuCenter for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Chang LiuGuangdong Provincial Engineering Research Center for Quality and Safety of Traditional Chinese Medicine, Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, China.
Xi ZhouGuangdong Provincial Engineering Research Center for Quality and Safety of Traditional Chinese Medicine, Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, China. 757648697@qq.com.
Huihui TiCenter for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China. tihuihui@126.com.

Funding

Department of Science and Technology of Guangdong Province No. 2024B1212070001National Natural Science Foundation of China - State Grid Corporation Joint Fund for Smart Grid No.81873071National Natural Science Foundation of China - State Grid Corporation Joint Fund for Smart Grid No.82574667the GDAS's Project of Science and Technology Development Nos. 2022GDASZH-2022010110
6 · The paper itself

Abstract

Pyrrolizidine alkaloids (PAs) are naturally occurring toxic secondary metabolites found in plants. However, the identification of PAs often relies on commercially available standards, which are expensive and limited in availability. To overcome this limitation, we developed molecular networks (MNs) from both data-dependent acquisition (DDA) and data-independent acquisition (DIA) data, utilizing specialized platforms tailored for each data type. Three approaches were employed for compound annotation: comparison with reference standards, library-based screening, and the deduction of candidate compounds based on precursor and characteristic fragment ions. Through the analysis of ten distinct herb species, DDA and DIA data led to the detection of 152 and 78 PA-like compounds, respectively. Meanwhile, several previously unreported compounds were identified, including 63 compounds in DDA data and 28 compounds in DIA data. Furthermore, a retention time (RT) prediction model was constructed using machine learning (ML) to enhance the accuracy of compound annotation. The prediction model, trained on 27 PA standards, exhibited a maximum error of 0.76 min in the test set, with an overall error within 1.5 min. The results show that there are 52.0% and 62.8% compound errors within 1.5 min for DDA and DIA data in the experiment. These combined methods significantly expand the number of detected compounds and improve the accuracy of PA annotation.

Indexed as

Machine LearningMass SpectrometryPyrrolizidine AlkaloidsPyrrolizidine AlkaloidsMachine learningMolecular networksNon-target screeningPyrrolizidine alkaloids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.